Adverse events within 7 days of administration; study participants aged 18-59 years | |
Adverse event reported |
Percentage (%) |
Local erythema |
9.0 |
Local swelling |
7.0 |
Pain at injection site |
58.6 |
Fatigue |
43.8 |
Headache |
44.4 |
Nausea |
15.5 |
Fever |
12.8 |
Myalgia |
39.1 |
Adverse events within 7 days of administration; study participants aged ≥60 years | |
Adverse event reported |
Percentage (%) |
Local erythema |
4.6 |
Local swelling |
2.7 |
Pain at injection site |
33.3 |
Fatigue |
29.7 |
Headache |
30.4 |
Nausea |
12.3 |
Fever |
3.1 |
Myalgia |
24.0 |